Skip to content
Tech News
clear
Topics: Today This Week This Month This Year
1.
Ozempic Breath Is on the Rise—and So Is This Unlikely Winner (gizmodo.com)
2.
GLP-1R–GIPR–PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice (feeds.nature.com)
3.
The Best GLP-1 Drug on the Market Is Even Better Than We Knew (gizmodo.com)
4.
I don’t think Gwyneth Paltrow knows what a peptide is (theverge.com)
5.
Tempo Promo Code: 60% Off Ready-to-Heat Meals in April 2026 (wired.com)
6.
Amazon launches GLP-1 weight loss program, promising 'fast, convenient' access (cnbc.com)
7.
With GLP‑1 drug ads everywhere, here’s what to know to safely buy them online (feeds.feedburner.com)
8.
Tempo Prepared Meal Subscription Review (2026): Surprisingly Tasty (wired.com)
9.
New York Times Makes Substantial Changes to Article That Glazed a Sleazy AI Startup: “Our Piece Should Have Included That Information” (futurism.com)
10.
Ozempic Shreds Bones? How a Small Study Turned Into a Big Health Myth (gizmodo.com)
11.
AI-Powered Drug Marketer Medvi Responds After Allegations About Fake Doctors and Patients (futurism.com)
12.
Why obesity drugs work better for some people: these genes hold clues (feeds.nature.com)
13.
Genetics reveal why people respond differently to GLP-1 weight-loss drugs (feeds.nature.com)
14.
Genetic predictors of GLP1 receptor agonist weight loss and side effects (feeds.nature.com)
15.
Gen Z wants their job to cover GLP-1 weight-loss drugs, survey suggests (feeds.feedburner.com)
16.
Why Is the New York Times Laundering the Reputation of a Sleazy AI Startup That’s Selling GLP-1s via a Dishonest Dumpster Fire of Fake Doctors, Phony Before-and-After Pictures, and Other Glaring Red Flags? (futurism.com)
17.
A new weight-loss pill is here, and it could reshape the GLP-1 market (feeds.feedburner.com)
18.
FDA Approves Eli Lilly’s GLP-1 Pill (wired.com)
19.
FDA Approves Eli Lilly's GLP-1 Pill (wired.com)
20.
Wall Street's rough month, Powell's inflation outlook, GLP-1 subscription and more in Morning Squawk (cnbc.com)
21.
Riding the GLP-1 boom, VITL lands $7.5M to overhaul cash-pay clinic prescribing (techcrunch.com)
22.
Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s (futurism.com)
23.
Ro CEO on the next phase of the Ozempic boom (feeds.feedburner.com)
24.
Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists (news.ycombinator.com)
25.
Heart Attack and Stroke Risk Jumps When People Stop Taking GLP-1s (news.ycombinator.com)
26.
Python Blood Could Kickstart the Next Big Thing in Weight Loss (gizmodo.com)
27.
Is It Safe to Inject Gray-Market Chinese Peptides? (futurism.com)
28.
Quitting Ozempic Could Hit Your Heart Hard, Study Finds (gizmodo.com)
29.
Your Off-Brand GLP-1 Is Dirtier Than You Think (gizmodo.com)
30.
Why smaller portions are the biggest restaurant trend right now (feeds.feedburner.com)
Today's top topics: openai samsung google android authority apple microsoft tsmc intel bose meta
View all today's topics →